On December 6, Axinn associate Josh Jowdy will moderate a webinar entitled, “FTC v. Amgen/Horizon: New Theories in Action” hosted by the American Bar Association’s Antitrust Law Section.

In May, the FTC and six states filed suit to block the merger of biopharmaceutical manufacturers Amgen, Inc. and Horizon Therapeutics plc. The litigation was settled in September with a behavioral remedy. The webinar, consisting of counsel on both sides and an economist involved in the litigation, will cover the allegations, the litigation, and the settlement.

Click here for more information, including how to register.